Clinical Trial: Cross-validation of a Predictive Model of Response to Anti-TNF Alpha Based on Oxylipin Response in Rheumatoid Arthritis

U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT06880146) titled 'Cross-validation of a Predictive Model of Response to Anti-TNF Alpha Based on Oxylipin Response in Rheumatoid Arthritis' on March 11.

Brief Summary: The goal of this clinical trial is to use a blood test to predict whether a participant diagnosed with rheumatoid arthritis will respond to anti-TNF alpha treatment . The main questions it aims to answer is:

Is the predictive model created using oxylipins effective?

Participants starting anti-TNF alpha treatment will have a blood sample taken before starting treatment and 6 months afterwards.

Study Start Date: March 15

Study Type: INTERVENTIONAL

Condition: Rheumatoid Arthritis

I...